Alkaloids in Erythrina by UPLC-ESI-MS and in Vivo Hypotensive Potential of Extractive Preparations
Total Page:16
File Type:pdf, Size:1020Kb
Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2015, Article ID 959081, 12 pages http://dx.doi.org/10.1155/2015/959081 Research Article Alkaloids in Erythrina by UPLC-ESI-MS and In Vivo Hypotensive Potential of Extractive Preparations Liara Merlugo,1,2 Marí C. Santos,2 Liane S. Sant’Anna,1,3 EversonW.F.Cordeiro,2 Luiz A. C. Batista,2 Silvia T. S. Miotto,4 Cássia V. Garcia,5 Cleci M. Moreira,1,3 and Andreas S. L. Mendez1,5 1 Programa de Pos-graduac´ ¸ao˜ em Bioqu´ımica, Universidade Federal do Pampa, BR 472 Km 585, Caixa Postal 118, 97508-000 Uruguaiana, RS, Brazil 2Laboratorio´ de Desenvolvimento e Controle de Qualidade de Medicamentos, Universidade Federal do Pampa, BR 472 Km 585, Caixa Postal 118, 97508-000 Uruguaiana, RS, Brazil 3Laboratorio´ de Fisiologia Cardiovascular, Universidade Federal do Pampa, BR 472 Km 585, Caixa Postal 118, 97508-000 Uruguaiana, RS, Brazil 4Departamento de Botanica,ˆ Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil 5Faculdade de Farmacia,UniversidadeFederaldoRioGrandedoSul,AvenidaIpiranga2752,90610-000PortoAlegre,RS,Brazil´ Correspondence should be addressed to Andreas S. L. Mendez; [email protected] Received 21 April 2015; Revised 19 July 2015; Accepted 28 July 2015 Academic Editor: Nunziatina De Tommasi Copyright © 2015 Liara Merlugo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Erythrina species are used in popular medicine as sedative, anxiolytic, anti-inflammatory, and antihypertensive. In this work, we investigated the chemical composition of extracts obtained from leaves of E. falcata and E. crista-galli.Thehypotensivepotential of E. falcata and the mechanism of action were also studied. The extracts were obtained by maceration and infusion. The total content of phenolic compounds and flavonoids was estimated by spectrophotometric methods. The chemical constituents were studied performing a chromatographic analysis by UPLC-ESI-MS. For in vivo protocols, blood pressure and heart rate were measured by the invasive hemodynamic monitoring method. Different concentrations of extracts and drugs such as L-NAME, losartan, hexamethonium, and propranolol were administrated i.v. The results of total phenolic contents for E. falcata and E. crista- galli were 1.3193–1.4989 mgGAE/mL for maceration and 0.8771–0.9506 mgGAE/mL for infusion. In total flavonoids, the content was 7.7829–8.1976 mg RE/g for maceration and 9.3471–10.4765 RE mg/g for infusion. The chemical composition was based on alkaloids, suggesting the presence of erythristemine, 11-methoxyglucoerysodine, erysothiopine, 11-hydroxyerysodine-glucose, and 11-hydroxyerysotinone-rhamnoside. A potent dose-dependent hypotensive effect was observed for E. falcata, which may be related to the route of -adrenergic receptors. 1. Introduction mechanism of action could have a vital role in the discovery of new products as therapeutic agents. Hypertension is a global health problem whose increased The genus Erythrina (Fabaceae) consists of 110 species, incidence can lead to the development of many chronic distributed in the tropical regions of America, Africa, Asia, diseases, as well as collaborating in the progression of chronic and Oceania [3, 4]. Phytochemical studies of its differ- kidney disease, and contribute to cardiovascular morbidity ent species showed a chemical constitution by alkaloids, and mortality [1]. Although there is a wide range of anti- flavonoids, pterocarpans, and cumarines [5–9]. Species as E. hypertensive drugs used in the control of hypertension, a velutina, E. mulungu, E. crista-galli,andE. falcata demon- successful treatment becomes even harder to achieve [2], so strated the predominance of alkaloids and flavonoids in the knowledge of medicinal plants, their composition, and their composition [10–14]. The alkaloids present in Erythrina 2 Evidence-Based Complementary and Alternative Medicine species have attracted much attention from researchers, since were analysed in a spectrophotometer Perkin Elmer UV-VIS they represent the main source of the tetracyclic alkaloids Lambda 35 (Norwalk, CT, USA) at 750 nm. The total phenolic of Erythrina type and have similar activities of the curare, content was expressed in milligrams of gallic acid equivalent causing muscle paralysis [15]. per mL of sample (mgGAE/mL). In popular medicine, these species are used for the treat- ment of respiratory diseases, as well as anxiolytic, sedative, 2.4. Total Flavonoid Content. The total flavonoid content was anti-inflammatory, and antihypertensive [11, 16]. Scientific determined by the method described by Chang et al. [23] studies showed different activities for these species such with some modifications. In a 25 mL flask 500 Lofsample as antibacterial, antifungal, and anti-inflammatory [17–19]. and 500 L of AlCl3 0.5% were added and the volume was Lehman [20] tested alcoholic extracts of E. americana and completed with water. It was incubated for 40 minutes at proved its hypotensive effect in rats, rabbits, and dogs. roomtemperatureandprotectedfromlightandreadingwas Alkaloids obtained from this species also demonstrated done in UV-VIS spectrophotometer Lambda 35 Perkin Elmer hypotensive activity [21]. (Norwalk, CT, USA) at a wavelength of 415 nm. The results The present study aimed to investigate the chemical were expressed in mg/g equivalents of rutin. composition of the species E. falcata and E. crista-galli by UPLC-ESI-MS and to evaluate the hemodynamic parameters 2.5. UPLC-MS. For the protocols a reverse-phase system was performed, using the following conditions: fast C18 analytical in rats, purposing to elucidate the involved mechanism of × action for E. falcata extracts. column Shim-pack XR-ODS (50 2 mm, 2.1 m); mobile phase consisted of acetonitrile : methanol 4 : 1 (v/v) and water with 0.1% formic acid (pH 3.0) with a flow rate of 0.2 mL/min; 2. Materials and Methods DAD detection at 340 nm; injection volume of 5.0 L. The elution gradient was as follows: 0% solvent A (0–2.5 min), 2.1. Plant Material. Erythrina crista-galli was collected in 0–5% A (2.5–7.5min), 5–10% A (7.5–10 min), 10–15% A (10– May 2013 in Uruguaiana, RS (Brazil). Erythrina falcata was 12.5 min), 15–20% A (12.5–15 min), 20–25% A (15–17.5 min), collectedinPortoAlegre,RS(Brazil),inFebruary2014.The 25% A (17.5–20 min), 25–60% A (20–27.5 min), 60% A (27.5– materials were identified and a voucher specimen of each 30 min), and 60–0% A (30–35 min). (Erythrina crista-galli,ICN183940;Erythrina falcata Benth., Chromatographic analyses were performed using an ICN 177665) was deposited at the ICN Herbarium (Instituto Acquity UPLC system (Waters Co., MA, USA) equipped with de Biociencias,ˆ UFRGS, Avenida Bento Gonc¸alves, 9500, binary solvent delivery system and autosampler. The DAD- Predio´ 43433, CEP 91501-970, Porto Alegre, RS, Brazil). UVandmassspectrometerEMQ-TOFMicro-Micromass (Waters Co., MA, USA) detectors were employed, with 2.2. Extracts Preparation. Leaves were selected and dried MassLynx v. 4.1 data acquisition software. ∘ at a temperature of 40 Cforfivedays.Afterthat,they The mass spectrometry analyses were performed in were grounded and submitted to exhaustive extraction pro- positive-ion mode and operated according to the following cesses by maceration using 40% ethanol as solvent (1 : 10, conditions: collision energy 4.0 eV; temperature of electro- ∘ ∘ plant : solvent) and by infusion using distilled water at a spray source and desolvation gas 100 Cand120C, respec- ∘ temperature of 100 C (1 : 15, plant : solvent). tively; capillary voltage 3000 V; sample cone 40 V; extraction For chromatographic assays, extracts obtained by mac- cone 3.0 V; N2 wasusedasthenebulizing.Massspectrawere eration process of both species were used. To reduce the recorded by using full scan mode in the range of m/z 200–800. impurities, extracts passed through a liquid-liquid extraction method by affinity solvents with increasing polarity (hex- 2.6. Hypotensive Activity and Mechanism of Action from ane, dichloromethane, ethyl acetate, and methanol) and for E. falcata Extracts further analysis they were filtered on a membrane of 0.45 2.6.1. Animals. Three-month-old male Wistar rats, weighing micrometers. around 300 g and purchased from the animal house of the For biological analyses macerations were used and infu- Universidade Federal de Santa Maria, were used. They were sions were obtained from E. falcata, which were oven-dried kept in cages with water available ad libitum, maintaining the and reduced to powder for subsequent redilution in 0.9% ∘ temperature controlled at 20–22 C with dark/light cycle of 12 saline solution for administration. hours. The experimental protocols followed the International 2.3. Total Phenolic Content. The total phenolic content was Principles for Research Involving Animals (Geneva) (Brazil- determined by Folin-Ciocalteu colorimetric method with ian legislation by law number 11.794/2008 (procedures for the some modifications [22]. For the analyses, aliquots of 100 L scientific use of animals), Decree 24.645/34 (animal rights), of the samples and standard solutions were transferred to approved by the Ethics Committee on Animal Use (CEUA), test tubes, where 500 L of Folin-Ciocalteu reagent and 6 mL Universidade Federal do Pampa (Protocol 030/2013)). of distilled water were added. Then, they were agitated and left at rest for 1 minute. After alkalizing the medium, 2mL 2.6.2. Hemodynamic Parameters. Rats were anesthetized of Na2CO3 solution 15% was added, and the volume was with urethane (1.4 mg/kg, i.p.) and submitted to surgery for completed to 10 mL with distilled water. After 30 minutes at catheterization of the carotid artery (to measure the hemody- room temperature and being protected from light, samples namic parameters) and the jugular vein (for administration of Evidence-Based Complementary and Alternative Medicine 3 the extracts and drugs).